PIEDMONT NEWNAN HOSPITAL INC. — History
CCN 110229 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$366M
Latest Revenue (FY2022)
+7.3%
Revenue CAGR (3yr)
19.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $318M | $345M | $366M | +6.2% | +7.3% |
| Operating Expenses | $251M | $286M | $296M | +3.3% | +8.5% |
| Operating Margin | 21.1% | 16.9% | 19.2% | +13.8% | -4.4% |
| Net Income | $67M | $58M | $70M | +20.9% | +2.5% |
| Licensed Beds | 164 | 164 | 177 | +7.9% | +3.9% |
| Total Patient Days | 54,148 | 58,279 | 57,521 | -1.3% | +3.1% |
| Medicare Day % | 24% | 22% | 23% | +4.2% | -2.0% |
| Medicaid Day % | 7% | 5% | 6% | +4.8% | -7.8% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +15.0% ($318M → $366M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.3%
This Hospital
+7.6%
State Avg
Latest Margin
19.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $390M | 18.3% |
| FY2024 (proj) | $414M | 17.4% |
| FY2025 (proj) | $438M | 16.5% |